James Parker

A portrait of the author.

James Parker

James Parker is a content writer from Coral Springs, Florida. He majored in Communication and Media Studies at Stetson University, where he spent much of his time bringing the cutting edge of medical research to his peers’ attention. When he's not writing, he enjoys rewatching "Almost Famous" or curling up with a good book.

Latest MedTruth Work by James Parker

Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
A photo of a phone and glasses to represent someone's desk as they sit down to read this week's MedTruth Weekly medical news report.

MT Weekly: Australia Fights BIA-ALCL, Ireland Refuses Recourse to Mesh-Injured

James Parker · October 21, 2019

Last week in medical brought about delay in an opioid trial against Purdue Pharmaceuticals and the Sackler family while the two determine how much of the settlement the Sacklers should pay. Meanwhile, actions were made against BIA-ALCL in Australia and Ireland, where warnings were sent to the public. Ireland's mesh-injured population is denied financial compensation for their harm.

News
Photo of phone, keyboard, and glasses on desk table to represent person about to read MedTruth Weekly.

MT Weekly: Research Sheds Light on BIA-ALCL, Australia Joins Litigation Against Monsanto

James Parker · October 14, 2019

Groundbreaking new research on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reveals complete removal of tumor growth during explant procedures may be safest. Meanwhile, limits on nicotine levels in e-cigarettes are proposed to protect the youth and Australia takes action against Monsanto.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Descovy Approved for PrEP, Overseas Action Against Breast Implants

James Parker · October 7, 2019

Johnson & Johnson sidesteps opioid trials, agreeing to a settlement of $20.4 million for affected counties in Ohio. Meanwhile, Descovy has been approved by FDA for HIV prevention, a court verdict falls in favor of California couple affected by J& J talc powder, and more bans are proposed on e-cigarattes and breast implants.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Arrests on Devil’s Highway and JUUL Labs’ New CEO

James Parker · September 30, 2019

Last week saw 38 arrests in Massachusetts along land known as the "Devil's Highway," where opioids are regularly sold. Meanwhile, Johnson & Johnson aims to evade cases against their talcum powder and transvaginal mesh to no avail. JUUL Labs' new CEO, Crosthwaite, has announced roll back on television ads and lobbying efforts while a federal investigation of their company is conducted. And in the fight against HIV, researchers may have found a new way to combat dormant HIV cells.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: J&J Mistrial Declared, 'No JUULS' Requested for Schools

James Parker · September 16, 2019

In this week's MT Weekly, Purdue Pharma and the Sacklers negotiated settlements, while pharmaceutical manufacturer Mallinckrodt agreed to a $30 million settlement. Trials on talc and Roundup brought stalemates. Still, global HIV efforts and criticisms of JUUL e-cigarettes bring hope for public health.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Robotic Devices for Breast Implants, Public Figures Protesting JUUL

James Parker · September 9, 2019

Our current installment of MT Weekly has updates on opioid epidemic initiatives, the J&J talcum powder trial, breast implant improvements, protests against JUUL and advancements in HIV research.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Sackler Family Subpoenas, JUUL's Global Strategy, Momentous HIV Breakthroughs

James Parker · August 27, 2019

Last week, the state of New York issued subpoenas to companies with relations to the Sackler family in attempts to track money spent on opioids. Additionally, JUUL announced interest in global markets, and HIV researchers discovered a potentially illuminating sample of the virus.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: California Roundup Warnings, HIV Treatment Drawbacks, JUUL Sues FDA

James Parker · August 19, 2019

In recent news, Roundup will no longer be labeled as carcinogenic in California. Meanwhile, JUUL files suit against the FDA to delay inspection of their e-cigarette. Medicare defraud, talc trial asbestos denials and issues surrounding access to HIV prevention medication are also covered.

Health Features
A photo of vintage cigarette boxes to represent the new FDA Cigarette Warning Label plan.

FDA Will Add Graphic Warning Labels to Cigarette Packages

James Parker · August 15, 2019

On Aug. 15, the U.S. Food and Drug Administration released a new rule requiring warning labels on cigarette boxes. Full-color cigarette warnings must be included on all cartons with images of side effects, including blindness, amputation and bladder cancer.

FDA Regulation
Illustration of MRI scan of lungs for mesothelioma as the FDA approves the first mesothelioma treatment in 15 years.

First New Mesothelioma Treatment in 15 Years Approved by FDA

James Parker · August 8, 2019

Manufactured by Novocure, the FDA-approved mesothelioma treatment, NovoTTF-100L is the newest option for MPM since Pemetrexed. NovoTTF-100L was approved under the FDA Humanitarian Device Exemption, which is an expedited regulatory pathway intended to approve treatments for rare diseases.

FDA Regulation
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: JUUL Addresses Concerns, Bayer Faces Setbacks, Taiwan to Ban Transvaginal Mesh

James Parker · August 2, 2019

In this week's health news, JUUL addresses health concerns raised by Yale University's recent research findings on the well-known e-cigarette product. Meanwhile, Bayer stock drops as the company faces more litigation and transvaginal mesh bans are discussed in the U.S. and abroad.

Health Features
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Historic Breast Implant Recall, Talc Trials Kept in State Courts

James Parker · July 26, 2019

In this week's news, Johnson & Johnson is officially denied transfer into federal court and Allergen announces breast implant recall from the market worldwide. Meanwhile, the opioid crisis wages on, California's latest mesh trial proceeds, and solutions for HIV are sought around the globe.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Surprising Opioid Stats, HIV Research Strides and Stalled Zofran Litigation

James Parker · July 18, 2019

In this week's MT Weekly, recently published opioid statistics reveal that prescriptions for opioids are actually down by a notable percentage. Additionally, successful treatment methods for HIV are underway, and Zofran litigation is stalled by the pharmaceutical company's request for an FDA statement.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Roundup Bans, Breast Implant Research and Medical Device Laws

James Parker · July 9, 2019

In recent news, Austria bans RoundUp while a U.S. judge orders a reduction of the $75 million punitive settlement. Numbers indicate a stronger correlation between BIA-ALCL and textured breast implants. The FDA also announced the end of their medical device alternative summary reporting system.

Health Features
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Man with Diabetic Neuropathy holding foot

A MedTruth Guide to Diabetic Neuropathy

James Parker · May 23, 2018

Our guide to diabetic neuropathy delves into different types of nerve damage, associated symptoms and potential treatment options.

Health Features
A photo depicting a doctor talking with diabetes patient after FDA warns of rare genital gangrene linked to SGLT2 Diabetes Drugs.

FDA Warns of Rare Genital Gangrene Linked to SGLT2 Diabetes Drugs

James Parker · September 17, 2018

People with diabetes taking Invokana and other SGLT2 inhibitors may be at risk for Fournier's gangrene, a flesh-eating bacterial infection affecting the groin and genitals. SGLT2 inhibitors that may potentially cause Fournier's gangrene include Invokana, Farxiga and Jardiance.

FDA Regulation
Electric gate system safety

How to Stay Safe with Electric Gate Systems

James Parker · June 26, 2018

In the past 20 years, hundreds of people around the world have been injured or killed by an electric gate. Understanding automatic gate safety is key for both businesses and homeowners.

Health Features
Woman clutching stomach because of hernia mesh repair

Doctors Need More Info to Choose the Best Mesh for Hernia Repair

James Parker · May 21, 2018

A recent study shows hernia mesh labels lack important info, which could increase the risk of complications for patients.

Health Features
Hands in a circle representing talcum powder cancer case

22 Women Win Talcum Powder Cancer Case

James Parker · August 16, 2018

A Missouri jury awarded $4.69 billion to compensate women who reportedly developed talcum powder ovarian cancer, delivering the largest product-defect verdict in U.S. history.

Legal Developments
Man sitting on floor thinking about diabetes and depression

Are Diabetes and Depression Linked?

James Parker · July 19, 2018

Depression is the leading cause of disability worldwide. For diabetics, it can have a big impact on safety and self-care.

Health Features
Calorie Labels in Restaurant Menus

New Calorie Labels in Restaurants May Be Useful in the Fight Against Obesity

James Parker · June 1, 2018

Since early May, all restaurants with more than 20 locations are required to add calorie labels to their menus.

News
Photo of man exhaling smoke from e-cigarette after FDA makes JUUL Public Health Warning for use by minors.

FDA Takes A Stand Against The Flood of Underage Juul Users

James Parker · September 12, 2018

As the use of Juul vaporizers and other e-cigarettes among teens rises, the FDA reviews the company's youth marketing efforts and fines retailers for selling to minors.

FDA Regulation
A photo of talcum powder spilling out onto a table, representing J&J covering up asbestos in talcum powder.

Reuters Exposes How Johnson & Johnson Covered Up Asbestos in Talc

James Parker · December 18, 2018

An investigation shows Johnson & Johnson hid the fact that trace amounts of asbestos has been detected in their talc for decades.

News
Illustration of fist holding e-cigarette after vaping linked to seizures.

FDA Announces Intent to Look Into Potential “Vape Seizures”

James Parker · April 4, 2019

The U.S. Food and Drug Administration (FDA) announced today that they would begin looking into a potential link in a series of vape seizures that seem to be affecting young adults. The FDA became aware of the issue when conducting reviews of adverse event reporting related to vape use as part of their initiative to fully define the direct and indirect risks associated with the product.

FDA Regulation
A photo of pills on Plavix regarding the FDA update

FDA Dismissed Citizen Petition for Plavix Labeling

James Parker · January 18, 2019

The FDA recently dismissed a petition to add a new black-box label to the popular blood thinner Plavix.

FDA Regulation
Photo of Vape Juice bottles after FDA warns of relationship between vape juice and erectile dysfunction.

FDA Warns of E-Cig Burns, Erectile Dysfunction Drugs in Vape Juice

James Parker · November 16, 2018

As the FDA struggles to regulate e-cigarette marker, the agency has warned against e-cig burns, device explosions and even liquids containing erectile dysfunction drugs.

FDA Regulation
A photo of two executives signing an agreement following Oklahoma and Purdue Pharmaceuticals $270 million settlement.

Purdue Settles for $270 Million in Oklahoma's Opioid Crisis

James Parker · April 17, 2019

The state of Oklahoma and Purdue Pharmaceuticals have agreed to a $270 million settlement to help combat the crippling issue of opioid addiction in rural America.

Legal Developments
An illustration of a gavel representing the recent $25 million-dollar mesothelioma talc verdict in New York.

J&J Mesothelioma Talc Verdict in New York May Exceed $25 Million

James Parker · May 22, 2019

A New York jury issued a $25 million verdict against J&J for its part in causing a 66-year-old woman's asbestos-related cancer. The woman, Donna Olson, used J&J's talc products for decades.

Legal Developments
Recalled pressure cooker

Pressure Cooker Recall: The Dangers of Defective Pressure Cookers

James Parker · June 8, 2018

A pressure cooker recall has been issued for multiple models that may explode, shock, or burn consumers. Because pressure cooker injuries can be serious, it's incredibly important to research recalled models and understand potential dangers.

News
US map representing OxyContin Lawsuit Against Perdue Pharmaceuticals

Half the Nation Unites Against Opioid Manufacturer

James Parker · July 6, 2018

In a crackdown attempt to fight the opioid crisis, 26 states are taking legal action against a major OxyContin manufacturer.

Legal Developments
Man wearing virtual reality headset to treat opioid addiction

Vanderbilt Tests VR Program To Treat Opioid Users

James Parker · April 23, 2018

An experimental therapy program, in development at Vanderbilt University, uses VR technology to treat opioid addiction.

MedTech
Talc in Cosmetics

Philippine FDA Warns of Talc in Cosmetics

James Parker · April 30, 2018

The Philippine FDA recently issued a consumer advisory about potential asbestos contamination in cosmetic talcum powder.

FDA Regulation
How SSRI antidepressants affect sex drive

SSRIs and Sex: How Antidepressants Affect Desire

James Parker · July 31, 2018

SSRIs are commonly prescribed to help people living with anxiety or depression. Unfortunately, there may be a sexual caveat to these medications.

Health Features
Woman holding clump of hair caused by Taxotere hair loss

Is Scalp Cooling a Treatment for Taxotere Hair Loss?

James Parker · May 14, 2018

The emergence of a new therapy known as scalp cooling may help women worried about permanent hair loss from Taxotere and other chemotherapy drugs.

News